TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DTIL

Precision BioSciences Inc

Healthcare · Biotechnology

6.70$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Precision BioSciences Inc (DTIL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.2% of the shares are freely tradable; institutional investors hold 65.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 65.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 92.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 28Mio.

Largest Shareholders

Institutions

Institutions DTIL
Name Stake (%) Shares Change (%) Date
Aberdeen Group PLC 8.08 2,230,178 +0.0 06/30/2026
Bleichroeder LP 6.02 1,662,500 +0.0 03/31/2026
Octagon Capital Advisors LP 4.89 1,350,000 -39.6 06/30/2026
BOOTHBAY FUND MANAGEMENT, LLC 3.86 1,066,050 +0.0 03/31/2026
Driehaus Capital Management LLC 3.61 995,371 +26.4 03/31/2026
Lynx1 Capital Management, LP 3.44 950,466 -3.5 06/30/2026
Vanguard Capital Management, LLC 3.30 910,740 +0.0 03/31/2026

Funds

Funds DTIL
Name Stake (%) Shares Change (%) Date
abrdn World Healthcare 4.15 1,144,208 +0.0 07/31/2026
abrdn Life Sciences Investors 3.93 1,085,970 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.82 778,139 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?